Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

• Asıl Yazarlar: Garyfallia Poulakou (Yazar), Maxime Barakat (Yazar), Robert J. Israel (Yazar), Marcelo R. Bacci (Yazar), Virazole Collaborator Group for COVID‐19 Respiratory Distress (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2023-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract There is an unmet medical need for effective treatments for hospitalized patients with coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with demonstrated in vitro activity against multiple viruses, including severe acute respiratory syndrome coronavirus 2 (SARS‐C...